Fil LTD Magenta Therapeutics, Inc. Transaction History

Fil LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$5.7 - $19.7 $3.59 Million - $12.4 Million	-629,599 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$5.57 - $11.65 $1.82 Million - $3.81 Million	-327,185 Reduced 34.2%	629,599 $3.59 Million
Q3 2018 Nov 09, 2018	BUY	$11.32 - $15.7 $1.48 Million - $2.05 Million	130,312 Added 15.77%	956,784 $11.5 Million
Q2 2018 Aug 10, 2018	BUY	$13.5 - $14.52 $11.2 Million - $12 Million	826,472 New	826,472 $11.2 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.